Accelerating Global Health Progress
Continuing on from the last World Health Assembly’s event to mark its 50th anniversary, the IFPMA convenes public health experts to discuss the future of global health.
Read More
Thought Leader Series on Vaccines
In this special series on vaccines, IFPMA invites key opinion leaders to advance thinking and ideas on key issues that can drive efforts to allow the “miracle” of life-saving vaccines to reach all.
Read More
50 Years of Global Health Progress Report
This report traces global health progress over the past 50 years. It reviews some of the research-based biopharmaceutical industry’s major scientific advances, as well as acknowledging challenges the industry faces and areas of unfinished business.
Read more
AMR Industry Alliance
Together with 100+ companies and trade associations from the AMR Industry Alliance, IFPMA is committed to stop superbugs. Check out our first Progress Report!
Read More
IFPMA HEALTH PARTNERSHIPS DIRECTORY
IFPMA hosts the Health Partnerships Directory, a continuously expanding online database that allows users to view, in depth, health partnerships from across the world that involve the research-based biopharmaceutical industry.
Read More
New IFPMA Code of Practice 2019
New IFPMA Code of Practice will enter into force on 1st January 2019
New CodeIFPMA in Brief
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Tackling Global health challenges
The research-based biopharmaceutical industry is proud to be playing its part in the quest to find effective and sustainable solutions to today’s most pressing health concerns.
Read More
Boosting Innovation and Access
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Read More
Building trust
The healthcare community and the public must be confident that research-based biopharmaceutical industry and their employees, wherever they operate, communicate and act in an ethical and professional manner.
Read More
Discovering medicines and Vaccines
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
Read More
Our Resources
Thought Leader Series on Vaccines
Vaccines are a key part of the ambition for Universal Health Coverage (UHC) and the United Nations Sustainable Development Goals (SDGs). Immunization not only saves lives and improves health, it also unlocks the potential of the community. By combining efforts, national policymakers, the vaccines industry and wider global health and...
Read More
IFPMA & IFPW Supply chain session 2016 Global Health Forum - long version
The session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential...
Read More
IFPMA Welcomes Set-Up of New African Medicines Agency
Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of 55-country African Union, all gathered at the 71st World Health Assembly, unanimously adopted a treaty to establish the African Medicines Agency, IFPMA seizes this momentum to welcome this important milestone. The new African Medicines Agency...
Read More
Greg Perry - IFPMA Moderated Panels @Pre-ICDRA 2018
Read More
IFPMA Statement at WHA72 12.1 agenda item Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits
Seasonal influenza virus sharing is already being negatively impacted by national implementation of the Nagoya Protocol in some countries. Several instances have been reported by the WHO Collaborating Centers where countries have delayed, or stopped altogether, the sharing of seasonal influenza virus samples on the grounds of conflict with local...
Read MoreJoin IFPMA
Our membership has three levels tailored to meet specific needs. Full Members have to be R&D-based pharmaceutical companies or national associations whose membership includes innovative pharmaceutical companies; Associate Members of R&D-based pharmaceutical companies and national associations whose permanent staff numbers are less than five, and Affiliate Members that are organizations, associations, companies and institutions who are supportive of the R&D-based
LEARN MOREOur Blog
Five questions to .... Kawaldip Sehmi
Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO) talks to IFPMA about why the Essential Medicines List is important for patients. What does the addition of new medicines on the 2019 EML update mean for patients? The inclusion of any medicine, including innovative and specialty medicines, on the World Health Organization’s Essential Medicines List (EML) is good news: it should increase patient...
Read More
Flu can cause up to 650,000 deaths a year globally
This blog was originally published on Health Awareness Value of Vaccines 2019 campaign on 27 June 2019. Influenza is a highly infectious disease that usually strikes during the winter season. Globally, it causes an estimated one billion cases of influenza, resulting in 290,000 to 650,000 deaths per year. A person can get the virus simply by being near an infected person that coughs, sneezes or...
Read More
Universal Health Coverage: Moving Together, Stronger Together
This blog was originally published on Health Policy Watch on 7 June 2019. The first-ever United Nations High-Level Meeting (UNHLM) on Universal Health Coverage (UHC), scheduled for 23 September 2019, will soon be upon us. The sense of urgency in preparing for this historic milestone in achieving global health progress was palpable during the World Health Assembly (WHA). There is no lack of often passionate...
Read MoreLatest Tweets
